Quintiles will become largest Asia-Pacific clinical development center

In 2009, Quintiles will relocate to a facility that is 80,000 square feet, which will double its size. The facility will open in Singapore, where since 1995, they have done more than 1,000 studies. Clinical Trials Today has the in depth story.

Anand Tharmaratnam, M.D., head of clinical development for Quintiles Asia Pacific, had this to say about the expansion:

“Firstly, a significant proportion of our customers are in Singapore and all of them are within a seven-hour direct flight from Singapore. Singapore is also connected by direct flights to a lot of our U.S. and European offices. Secondly, we are able to hire talent with multinational company experience in Singapore, and we are able to attract foreign talent to relocate to Singapore who find it a stable, secure and welcoming environment to live in as a foreigner. Thirdly, it is an attractive place from which to manage a business with very high ethical and transparent governance standards with an effective tax structure. Fourth, it is increasingly becoming a global hub for scientific excellence and innovation.”